Low within- and between-day variability in exposure to new insulin glargine 300 U/ml

AIMS: To characterize the variability in exposure and metabolic effect of insulin glargine 300 U/ml (Gla-300) at steady state in people with type 1 diabetes (T1DM). METHODS: A total of 50 participants with T1DM underwent two 24-h euglycaemic clamps in steady-state conditions after six once-daily adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, R H A, Nowotny, I, Teichert, L, Bergmann, K, Kapitza, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674964/
https://www.ncbi.nlm.nih.gov/pubmed/25425394
http://dx.doi.org/10.1111/dom.12416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674964/
https://www.ncbi.nlm.nih.gov/pubmed/25425394
http://dx.doi.org/10.1111/dom.12416

Ejemplares similares